ALX Oncology Holdings Inc. (ALXO) P/B ratio

P/B ratio today
2.1×

ALX Oncology Holdings Inc. (ALXO) trades at 2.1× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 2.3×. That is 204.3% higher than the 0.8× of fiscal 2024. Figures as of 18 Nov 2026, 10:44 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio today
2.1×
P/B ratio, fiscal 2025
2.3×
Change on fiscal 2024
+204.3%
Highest on record
3.7×fiscal 2020
Lowest on record
0.8×fiscal 2024
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

ALX Oncology Holdings Inc. P/B ratio, in more detail

Today's figure is 11.1% below the fiscal 2025 year-end.

Across the 6 fiscal year-ends on record (2020–2025), the highest was 3.7× in fiscal 2020 and the lowest 0.8× in fiscal 2024. Today's P/B ratio is higher than at 33% of the 6 fiscal year-ends on record; their median is 2.4×.

History · 6 fiscal years

P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

ALX Oncology Holdings Inc. P/B ratio, year by year

ALX Oncology Holdings Inc. (ALXO) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
Today2.1×—$1.01—
20252.3× 204.3% up$1.13$0.48
20240.8× 77.3% down$1.67$2.18
20233.4× 93.8% up$14.89$4.41
20221.7× 27.0% down$11.27$6.47
20212.4× 35.6% down$21.49$9.01
20203.7×—$86.20$23.25
2019———-$22.96
2018———-$18.82

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

More on ALXO

ALX Oncology Holdings Inc., figure by figure

ALX Oncology Holdings Inc. (ALXO) overview: price, valuation and scorecard

ALX Oncology Holdings Inc. P/B ratio: questions and answers

What is ALX Oncology Holdings Inc.'s P/B ratio?

ALX Oncology Holdings Inc. (ALXO) trades at 2.1× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 2.3×. That is 204.3% higher than the 0.8× of fiscal 2024.

Is ALX Oncology Holdings Inc.'s P/B ratio high or low compared with its own history?

Today's P/B ratio is higher than at 33% of the 6 fiscal year-ends on record; their median is 2.4×.

What are the highest and lowest P/B ratio figures on record for ALX Oncology Holdings Inc.?

Across the 6 fiscal year-ends on record (2020–2025), the highest was 3.7× in fiscal 2020 and the lowest 0.8× in fiscal 2024.

How is ALX Oncology Holdings Inc.'s P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For ALX Oncology Holdings Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ALX Oncology Holdings Inc. (ALXO) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ALXO/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.